Menno R. Vriens

Clinical Spectrum of Pheochromocytoma

Marlon A. Guerrero, Jennifer M. J. Schreinemakers, Menno R. Vriens et al. · Journal of the American College of Surgeons · 2009 · 184 citations

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Paloma Cejas, Yotam Drier, Koen M.A. Dreijerink et al. · Nature Medicine · 2019 · 179 citations · Full text

Tumor Biology, Pancreatic Cancer, Medicine +6

Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors

Roeland F. de Wilde, Christopher M. Heaphy, Anirban Maitra et al. · Modern Pathology · 2012 · 174 citations

Pancreatic Cancer, Medicine, Alternative Lengthening +8

MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients

Joanne M. de Laat, Rob B. van der Luijt, Carolina R C Pieterman et al. · BMC Medicine · 2016 · 142 citations · Full text

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

Wenzel M. Hackeng, Lodewijk A.A. Brosens, Joo Young Kim et al. · Gut · 2021 · 138 citations · Full text